Potential new target for early treatment of Alzheimer's disease
UNIVERSITY PARK, Pa. — A class of proteins that regulates cell repair and enhances cell growth-signaling systems could be a promising new target for the treatment of Alzheimer's and other neurodegenerative diseases, according to a new study led by researchers at Penn State. They found that disrupting necessary sugar modifications of these proteins promotes cell repair and reverses cellular abnormalities that occur in neurodegenerative diseases.
The study appeared today (July 2) in the journal iScience, and the researchers have a patent related to this work.
“Strategies ...













